AMD vs PFE: Which Is the Better Buy?

Side-by-side comparison of Advanced Micro Devices, Inc. and Pfizer Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Advanced Micro Devices, Inc. Β· Technology
$614.61
-13.7% upside to fair value
Med Conviction Grade C
VS
Pfizer Inc. Β· Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
PFE has more upside to fair value (+12.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMD PFE
Current Price $614.61 $27.64
Fair Value Estimate $530.25 $30.94
Upside to Fair Value -13.7% +12.0%
Market Cap $1,002.2B $157.5B
Forward P/E β€” β€”
EV / EBITDA 93.4x 17.4x
Price / Sales 24.3x 2.5x
Price / FCF 119.3x 14.3x
Revenue Growth YoY +50.1% +2.6%
Gross Margin 53.2% 71.3%
Operating Margin 15.7% 25.1%
Return on Equity 10.1% 4.9%
Dividend Yield 0% 6.22%
FCF Yield 0.84% 6.97%
Analyst Consensus Strong Buy Hold
Investment Thesis
AMD β€” Advanced Micro Devices, Inc.
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
PFE β€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
Metric AMD PFE
Zone Low $397.69 $23.21
Zone High $450.71 $26.30
In Buy Zone? No No
← AMD Research    PFE Research β†’    All Research